Philipp Krausewitz (P Krausewitz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 31

Top Topics

Positron Emission Tomography

Prostate Cancer

Top Venues

World journal of urology

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Philipp Krausewitz, Angelika Borkowetz, Gernot Ortner, Kira Kornienko, Mike Wenzel, Niklas Westhoff, null null
Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis. World journal of urology 42 (1) (2024)
Philipp Krausewitz, Angelika Borkowetz, Gernot Ortner, Kira Kornienko, Mike Wenzel, Niklas Westhoff, null null
Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis. World journal of urology 42 (1) (2024)
Lara Samirae, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
The relevance of circRNAs in serum of patients undergoing prostate biopsy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Thomas Büttner, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Joerg Ellinger, Philipp Krausewitz, Manuel Ritter
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers 16 (3) (2024)
Philipp Krausewitz, Angelika Borkowetz, Gernot Ortner, Kira Kornienko, Mike Wenzel, Niklas Westhoff, null null
Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis. World journal of urology 42 (1) (2024)
Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center. BMC urology 24 (1) (2024)
Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center. BMC urology 24 (1) (2024)
Thomas Büttner, Niklas Klümper, Richard Weiten, Philipp Lossin, Stefan Latz, Carolin Jacobs, Manuel Ritter, Stefan Hauser, Joerg Ellinger, Philipp Krausewitz
Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer. The Prostate 84 (12) (2024)
Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center. BMC urology 24 (1) (2024)
Thomas Büttner, Florian Gärtner, Markus Essler, Richard Weiten, Glen Kristiansen, Joerg Ellinger, Manuel Ritter, Philipp Krausewitz
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy. The Prostate (2024)
Thomas Büttner, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Joerg Ellinger, Philipp Krausewitz, Manuel Ritter
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers 16 (3) (2024)
Lara Samirae, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
The relevance of circRNAs in serum of patients undergoing prostate biopsy. International journal of urology : official journal of the Japanese Urological Association (2024)
Thomas Büttner, Niklas Klümper, Richard Weiten, Philipp Lossin, Stefan Latz, Carolin Jacobs, Manuel Ritter, Stefan Hauser, Joerg Ellinger, Philipp Krausewitz
Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer. The Prostate (2024)
Lara Samirae, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
The relevance of circRNAs in serum of patients undergoing prostate biopsy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Philipp Krausewitz, Angelika Borkowetz, Gernot Ortner, Kira Kornienko, Mike Wenzel, Niklas Westhoff, null null
Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis. World journal of urology 42 (1) (2024)
Thomas Büttner, Florian Gärtner, Markus Essler, Richard Weiten, Glen Kristiansen, Joerg Ellinger, Manuel Ritter, Philipp Krausewitz
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy. The Prostate 84 (8) (2024)
Richard Weiten, Enno Storz, Carolina Kessler, Laurenz Sperber, Hanna Elisa Spohn, David Johannes Karl Paul Pfister, Tim Nestler, Yuri Tolkach, Friederike Linden, Ralph Wirtz, Melanie von Brandenstein, Philipp Krausewitz, Axel Heidenreich
Trophoblast cell surface antigen-2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma. BJU international (2024)
Richard Weiten, Enno Storz, Carolina Kessler, Laurenz Sperber, Hanna Elisa Spohn, David Johannes Karl Paul Pfister, Tim Nestler, Yuri Tolkach, Friederike Linden, Ralph Wirtz, Melanie von Brandenstein, Philipp Krausewitz, Axel Heidenreich
Trophoblast cell surface antigen-2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma. BJU international (2024)
Leon M Bischoff, Johannes M Peeters, Leonie Weinhold, Philipp Krausewitz, Joerg Ellinger, Christoph Katemann, Alexander Isaak, Oliver M Weber, Daniel L R Kuetting, Ulrike I Attenberger, Claus Christian Pieper, Alois M Sprinkart, Julian Alexander Luetkens
Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI. Radiology 308 (3) (2023)
Philipp Krausewitz, Helene Schmeller, Carsten Spitzer, Joerg Ellinger, Manuel Ritter, Katja Petrowski, Rupert Conrad
Emotion-centered versus fact-centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial. The Prostate 84 (4) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Philipp Krausewitz, Helene Schmeller, Carsten Spitzer, Joerg Ellinger, Manuel Ritter, Katja Petrowski, Rupert Conrad
Emotion-centered versus fact-centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial. The Prostate 84 (4) (2023)
Philipp Krausewitz, R A Bundschuh, F C Gaertner, M Essler, U Attenberger, J Luetkens, G Kristiansen, M Muders, C-H Ohlmann, S Hauser, J Ellinger, M Ritter
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial. Trials 24 (1) (2023)
Philipp Krausewitz, R A Bundschuh, F C Gaertner, M Essler, U Attenberger, J Luetkens, G Kristiansen, M Muders, C-H Ohlmann, S Hauser, J Ellinger, M Ritter
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial. Trials 24 (1) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Philipp Krausewitz, R A Bundschuh, F C Gaertner, M Essler, U Attenberger, J Luetkens, G Kristiansen, M Muders, C-H Ohlmann, S Hauser, J Ellinger, M Ritter
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial. Trials 24 (1) (2023)
Philipp Krausewitz, Helene Schmeller, Carsten Spitzer, Joerg Ellinger, Manuel Ritter, Katja Petrowski, Rupert Conrad
Emotion-centered versus fact-centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial. The Prostate (2023)
Philipp Krausewitz, Helene Schmeller, Julian Luetkens, Darius Dabir, Jörg Ellinger, Manuel Ritter, Rupert Conrad
Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients' expectancy? World journal of urology 40 (9) (2022)
Philipp Krausewitz, Niklas Klümper, Ayk-Peter Richter, Thomas Büttner, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis. Cancers 14 (18) (2022)
Philipp Krausewitz, Dorothea Fostitsch, Richard Weiten, Niklas Kluemper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Jörg Ellinger, Manuel Ritter
Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study. World journal of urology (2022)
Philipp Krausewitz, Mahmoud Farzat, Jörg Ellinger, Manuel Ritter
Omitting routine cystography after RARP: Analysis of complications and readmission rates in suprapubic and transurethral drained patients. International journal of urology : official journal of the Japanese Urological Association (2022)